Patent Leaderboard
USPTO Patent Rankings Data through Sept 30, 2025
CW

Catherine White

Merck: 17 patents #618 of 9,382Top 7%
LYLycera: 7 patents #9 of 35Top 30%
Newton, MA: #328 of 2,747 inventorsTop 15%
Massachusetts: #6,946 of 88,656 inventorsTop 8%
Overall (All Time): #271,564 of 4,157,543Top 7%
17 Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
11319283 Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Meredeth A. McGowan, Abdelghani Achab, Xavier Fradera, Yongxin Han, Derun Li +6 more 2022-05-03
11319295 Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Meredeth A. McGowan, Yongxin Han, Nunzio Sciammetta 2022-05-03
11111232 Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Yongxin Han, Derun Li +7 more 2021-09-07
11103493 Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Hua Zhou, Xavier Fradera, Yongxin Han, Meredeth A. McGowan, Nunzio Sciammetta +1 more 2021-08-31
10995085 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more 2021-05-04
10745364 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2020-08-18
10647705 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Yongxin Han, Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau +8 more 2020-05-12
10442819 Tricyclic compounds as inhibitors of mutant IDH enzymes Christian Fischer, Stephane L. Bogen, Matthew L. Childers, Francesc Xavier Fradera Llinas, J. Michael Ellis +28 more 2019-10-15
10377768 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein +3 more 2019-08-13
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2019-03-05
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +6 more 2017-10-10
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-05-30
9657033 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein +3 more 2017-05-23
9493441 Acyclic cyanoethylpyrazoles as janus kinase inhibitors Jason D. Brubaker, Joshua Close, Joon Jung, Michelle Martinez, Kevin J. Wilson +2 more 2016-11-15
9226922 Compounds that are ERK inhibitors Kevin J. Wilson, David J. Witter, Matthew H. Daniels, Angie R. Angeles, Phieng Siliphaivanh +16 more 2016-01-05
8344144 Inhibitors of Janus kinases Michelle R. Machacek, Gabriela de Almeida, Jonathan B. Grimm, Rachel N. MacCoss, Eric T. Romeo +2 more 2013-01-01